Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Marketing
Amid a new MASH market, ‘tremendous change’ is on the horizon
With the FDA approval of the first specific drug for MASH in March, Madrigal’s Rezdiffra is a pioneer in a market that is set for rapid change.
Ben Adams
Nov 5, 2024 10:02am
After extended shortage, all Ozempic, Wegovy doses on tap in US
Oct 31, 2024 2:40pm
UK warns GLP-1s not for 'body beautiful picture for Instagram'
Oct 25, 2024 8:20am
Novo asks FDA to prevent compounders from making GLP-1 knockoffs
Oct 23, 2024 2:29pm
Consumer groups urge FTC to block Novo Holdings' Catalent deal
Oct 18, 2024 10:20am
Novo settles with Mylan over potential Ozempic generic
Oct 7, 2024 9:18am